The purpose of this study is to determine if the opioid agonist effects of doses of 4/1 mg, 8/2 mg, and 16/4 mg of buprenorphine/naloxone can be completely blocked by 50 mg of oral naltrexone. This study will provide data to support the design of a similar study of the depot formulation of naltrexone and ultimately to study this combination for the treatment of cocaine dependence.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
8
4/1mg, 8/2mg 16/4mg
Drug Dependence Research Center
San Francisco, California, United States
Opioid Effects of study drug
Time frame: daily
Adverse Events
Time frame: Daily
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.